About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Obstructive Sleep Apnea is a high-yield USMLE Step 2 CK respiratory topic requiring diagnosis plus next-best-step management
- Severity assessment comes first: unstable patients need immediate stabilization before definitive diagnostic workup
- Use US guideline pathways, imaging, physiology, microbiology, pathology, or risk scoring depending on the condition
- Management depends on cause, severity, comorbidities, and risk of complications
- Exam stems often hinge on classic clues, contraindications, and when to escalate to imaging, procedure, or ICU care
Overview
Obstructive sleep apnea is a sleep-related breathing disorder caused by recurrent collapse of the pharyngeal airway during sleep. Events cause oxygen desaturation, sympathetic surges, fragmented sleep, and cardiovascular stress.
Epidemiology
OSA is highly prevalent in the United States, especially among adults with obesity, older adults, men, and postmenopausal women. It is particularly common in patients with resistant hypertension, atrial fibrillation, type 2 diabetes, heart failure, and stroke.
Clinical Features
Symptoms
Progressive or acute dyspnea depending on severity and underlying cause
Cough, chest discomfort, fatigue, or exercise limitation
Fever, weight loss, night sweats, or hemoptysis when infection or malignancy is present
Syncope, confusion, severe hypoxemia, or rapidly worsening respiratory distress
Symptoms may be absent when the condition is detected incidentally
Signs
Abnormal breath sounds, crackles, wheeze, dullness, or reduced air entry depending on pathology
Tachypnea, tachycardia, or oxygen desaturation when clinically significant
Cyanosis, hypotension, altered mental status, or respiratory exhaustion
Clubbing, lymphadenopathy, cachexia, or signs of chronic disease when present
Physical examination can be normal in early or mild disease
Investigations
First-line
STOP-BANG questionnaireSnoring, Tiredness, Observed apnea, Pressure, BMI, Age, Neck circumference, Gender. Screens risk but does not diagnose OSA
PolysomnographyGold standard, especially with significant cardiopulmonary disease, opioid use, suspected central sleep apnea, or hypoventilation
Home sleep apnea testAppropriate for uncomplicated adults with high pretest probability of moderate to severe OSA
Second-line
Laboratory testingCBC, CMP, inflammatory markers, cultures, viral testing, autoimmune tests, or disease-specific markers depending on presentation
Pulmonary function testingUseful for chronic dyspnea, obstructive/restrictive patterns, DLCO, and treatment response
Microbiology or pathologySputum studies, cytology, biopsy, or fluid analysis when infection, cancer, or inflammatory disease is suspected
Specialist
Specialist referralPulmonology, infectious disease, oncology, sleep medicine, critical care, or thoracic surgery depending on diagnosis and severity
Advanced testingBronchoscopy, PET-CT, sleep study, HRCT, echocardiography, or interventional radiology procedures when indicated
1
Positive airway pressure
- CPAP or auto-PAP is first-line for symptomatic moderate to severe OSA
- BiPAP may be used if CPAP intolerance, high pressure needs, hypoventilation, or selected comorbid respiratory disorders exist
- Assess adherence, mask fit, leak, nasal congestion, and residual AHI
2
Lifestyle and risk reduction
- Weight loss for overweight or obese patients
- Avoid alcohol, sedatives, and opioids near bedtime when possible
- Positional therapy for positional OSA
- Treat nasal obstruction and allergic rhinitis if contributing
3
Alternatives to PAP
- Mandibular advancement device for mild to moderate OSA or CPAP intolerance
- Upper-airway surgery or hypoglossal nerve stimulation in selected patients after specialist evaluation
- Counsel against drowsy driving until adequately treated
Complications
- Respiratory failure: Severe disease can progress to hypoxemia, hypercapnia, or need for ventilatory support
- Secondary infection: Damaged or obstructed lung is prone to bacterial infection
- Pulmonary hypertension: Chronic hypoxemia or parenchymal disease can increase pulmonary vascular resistance
- Delayed diagnosis: Incidental or nonspecific presentations may hide malignancy, TB, PE, or ILD
- Treatment toxicity: Antimicrobials, corticosteroids, anticoagulants, chemotherapy, or procedures can cause harm
USMLE Step 2 CK Exam Tips
- 1Loud snoring + witnessed apneas + daytime sleepiness in an obese patient = OSA
- 2Diagnosis is polysomnography or home sleep apnea testing, not STOP-BANG alone
- 3AHI >=30 is severe OSA
- 4First-line treatment for symptomatic moderate to severe OSA = CPAP
- 5Resistant hypertension should trigger evaluation for OSA
- 6OSA is a common reversible contributor to atrial fibrillation recurrence
- 7Elevated serum bicarbonate in obese sleepy patient suggests obesity hypoventilation syndrome, not uncomplicated OSA
practicetest your knowledge on obstructive sleep apneaApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — respiratory and beyond.
open q-bank